France donates 184,000 doses of AstraZeneca to Senegal via COVAX
France has donated 184,000 doses of the COVID-19 vaccine from AstraZeneca (AZN.L) to Senegal via the COVAX vaccine sharing center, the program’s sponsors announced in a statement on Thursday.
This is the second batch of COVID-19 vaccines that Senegal is receiving under the global program, after the arrival of 324,000 initial doses of AstraZeneca in March.
The arrival of the last batch is timely. Senegal’s vaccine supply is running out as thousands of people need to receive their second vaccine. Most of the country’s 16 million citizens have yet to receive a first dose.
About 456,000 people in Senegal had been vaccinated on Tuesday, program sponsors said, using a combination of doses acquired through COVAX and purchased in China.
Senegal has recorded around 41,500 cases of coronavirus and 1,142 deaths since the start of the pandemic, according to figures from the African Centers for Disease Control and Prevention.
Some 1.5 billion doses of the COVID-19 vaccine have been administered worldwide, but only about 1% of them in Africa, according to the World Health Organization.
France’s donation to Senegal follows pledges from several major economies to increase contributions to COVAX, which is supported by the WHO and the Global Alliance for Vaccines and Immunization (GAVI) and aims to secure $ 2 billion vaccine doses for low-income countries by the end of this year.
Our Standards: The Thomson Reuters Trust Principles.